Valuation : Qlife Holding AB

Market Cap 53.88M 5.63M 4.85M 4.56M 4.17M 7.79M 532M 7.81M 20.91M 273M 21.15M 20.69M 879M P/E 2024
-0.26x
P/E 2025 -1.73x
Enterprise Value 66.9M 6.99M 6.02M 5.66M 5.17M 9.68M 660M 9.7M 25.96M 339M 26.26M 25.69M 1.09B EV / Sales 2024
222x
EV / Sales 2025 178x
Free-Float
60.05%
Yield 2024 *
-
Yield 2025 -
1 day+3.67%
1 week+3.78%
Current month+4.48%
1 month+4.48%
3 months-11.56%
6 months-4.80%
Current year-34.30%
1 week 1.61
Extreme 1.608
1.88
1 month 1.61
Extreme 1.608
1.93
Current year 1.61
Extreme 1.608
3.09
1 year 1.2
Extreme 1.205
3.8
3 years 1.2
Extreme 1.205
179
5 years 1.2
Extreme 1.205
82,900
10 years 1.2
Extreme 1.205
120,000
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 2018-12-31
Chief Executive Officer 59 2019-10-10
Director of Finance/CFO 60 2023-10-31
Director TitleAgeSince
Director/Board Member 59 2020-12-31
Director/Board Member 52 2022-12-31
Chairman 61 2025-03-20
Date Insider Type Main position Quantity % Market Cap. Importance
6/14/23 Free

Chief Executive Officer

12,697,080 2.1166%
6/14/23
Qlife ApS
OthersCompany 40,630,656 6.7731%
6/13/23 Free

Chief Financial Officer

5,078,832 0.8466%
Change 5-day change 1-year change 3-year change Capi.($)
+3.67%+3.78%-47.29%-97.97% 5.63M
-0.42%-3.68%-18.51%+7.39% 187B
+1.15%+3.22%+1.37%+17.42% 120B
-1.86%+2.77%+13.15%+91.44% 63.15B
-1.31%-1.09%+17.67%+43.65% 51.75B
-1.54%-2.52%-3.98%-32.30% 50.32B
-2.02%-3.22%+9.18%-12.39% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-15.78% 23.93B
-1.44%-4.21%-8.07%+11.30% 22.99B
Average -0.46%+0.31%-0.10%+1.42% 58.53B
Weighted average by Cap. -0.55%+0.02%-1.43%+16.92%

Financials

2024 2025
Net sales 50K 5.23K 4.5K 4.23K 3.87K 7.23K 493K 7.25K 19.4K 253K 19.63K 19.2K 816K 324K 33.87K 29.14K 27.42K 25.05K 46.86K 3.2M 46.98K 126K 1.64M 127K 124K 5.29M
Net income -55.92M -5.85M -5.03M -4.73M -4.32M -8.09M -552M -8.11M -21.7M -283M -21.95M -21.47M -912M -20.56M -2.15M -1.85M -1.74M -1.59M -2.97M -203M -2.98M -7.98M -104M -8.07M -7.89M -335M
Net Debt 5.98M 625K 538K 506K 463K 865K 59.06M 868K 2.32M 30.3M 2.35M 2.3M 97.61M 13.02M 1.36M 1.17M 1.1M 1.01M 1.88M 129M 1.89M 5.05M 65.94M 5.11M 5M 212M
Logo Qlife Holding AB
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Employees
2
Date Price Change Volume
26-09-04 SEK 1.866 +3.67% 32,596
26-09-03 SEK 1.800 +2.97% 64,949
26-09-02 SEK 1.748 -1.58% 48,914
26-09-01 SEK 1.776 -0.56% 3,377
26-08-31 SEK 1.786 -0.67% 32,626

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QLIFE Stock